![Eric Curtis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric Curtis
No open positions remaining
Net worth: - $ as of 2026-08-30
Profile
Eric L.
Curtis worked at Bayer HealthCare as Vice President & General Manager-Rare Disease from 2012 to 2014.
From 2014 to 2016, worked at Aegerion Pharmaceuticals, Inc. as President-US Commercial.
From 2018 to 2020, worked at LadRx Corp.
as President & Chief Operating Officer.
Served as President & Chief Executive Officer at Centurion BioPharma Corp.
Education includes undergraduate studies at the University of Pittsburgh and an MBA from The Pennsylvania State University, conferred in 1999.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-07-22 | 1 ( 0% ) | 0 $ | 2026-08-30 |
Former positions of Eric Curtis
| Companies | Position | End |
|---|---|---|
| WINDTREE THERAPEUTICS, INC. | Chief Operating Officer | 2026-01-04 |
| LADRX CORPORATION | President | 2020-03-07 |
| AEGERION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2015-12-31 |
Bayer HealthCare
 Bayer HealthCare Medical/Nursing ServicesHealth Services Provides medical care, and animal health care services | Corporate Officer/Principal | 2013-12-31 |
Centurion BioPharma Corp.
 Centurion BioPharma Corp. Pharmaceuticals: MajorHealth Technology Founded in 1949, Centurion BioPharma Corp. is a Turkish pharmaceutical and American biopharmaceutical company specializing in sterile injectable products, blood products, vaccines, biosimilars, and biotechnological treatments, with a focus on rare diseases and chronic conditions. The company is based in DE. The company operates a state-of-the-art, EU GMP-certified manufacturing facility and maintains robust in-house R&D capabilities, including advanced laboratories and a skilled scientific team developing innovative generic drugs, biosimilars, and high value-added pharmaceuticals. Centurion collaborates through joint R&D, technology transfer, and licensing agreements to expand its product portfolio and market presence both domestically and internationally, including submissions for EU and other market authorizations. The company provides pharmacovigilance services aligned with national and EU regulations to monitor drug safety and efficacy and actively combats illegal and counterfeit sales of its products. Centurion BioPharma also focuses on the development of personalized medicine for solid tumor treatment, utilizing its LADR™ (Linker Activated Drug Release) technology to deliver anti-cancer therapies that target tumors more precisely. | Chief Executive Officer | - |
Education of Eric Curtis
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
61
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
LadRx Corp.
 LadRx Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical research and development oncology company | Health Technology |
Windtree Therapeutics, Inc.
 Windtree Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel therapeutics to address significant unmet medical needs in acute care markets | Health Technology |
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for hyperlipidemia and metabolic diseases | Health Technology |
University of Pittsburgh
 University of Pittsburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Pennsylvania State University
 The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bayer HealthCare
Bayer HealthCare Medical/Nursing ServicesHealth Services Provides medical care, and animal health care services | Health Services |
Centurion BioPharma Corp.
Centurion BioPharma Corp. Pharmaceuticals: MajorHealth Technology Founded in 1949, Centurion BioPharma Corp. is a Turkish pharmaceutical and American biopharmaceutical company specializing in sterile injectable products, blood products, vaccines, biosimilars, and biotechnological treatments, with a focus on rare diseases and chronic conditions. The company is based in DE. The company operates a state-of-the-art, EU GMP-certified manufacturing facility and maintains robust in-house R&D capabilities, including advanced laboratories and a skilled scientific team developing innovative generic drugs, biosimilars, and high value-added pharmaceuticals. Centurion collaborates through joint R&D, technology transfer, and licensing agreements to expand its product portfolio and market presence both domestically and internationally, including submissions for EU and other market authorizations. The company provides pharmacovigilance services aligned with national and EU regulations to monitor drug safety and efficacy and actively combats illegal and counterfeit sales of its products. Centurion BioPharma also focuses on the development of personalized medicine for solid tumor treatment, utilizing its LADR™ (Linker Activated Drug Release) technology to deliver anti-cancer therapies that target tumors more precisely. | Health Technology |
- Stock Market
- Insiders
- Eric Curtis
